Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-22-001398
Filing Date
2022-11-07
Accepted
2022-11-07 16:13:34
Documents
49
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cdio_10q-093022.htm   iXBRL 10-Q 498732
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 7815
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 7708
4 EXHIBIT 32.1 ex32x1.htm EX-32.1 3937
5 EXHIBIT 32.2 ex32x2.htm EX-32.2 3542
  Complete submission text file 0001079973-22-001398.txt   2770152

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cdio-20220930.xsd EX-101.SCH 28982
7 XBRL CALCULATION FILE cdio-20220930_cal.xml EX-101.CAL 30417
8 XBRL DEFINITION FILE cdio-20220930_def.xml EX-101.DEF 128163
9 XBRL LABEL FILE cdio-20220930_lab.xml EX-101.LAB 191240
10 XBRL PRESENTATION FILE cdio-20220930_pre.xml EX-101.PRE 175651
43 EXTRACTED XBRL INSTANCE DOCUMENT cdio_10q-093022_htm.xml XML 294150
Mailing Address 400 N ABERDEEN ST, SUITE 900 CHICAGO IL 60642
Business Address 400 N ABERDEEN ST, SUITE 900 CHICAGO IL 60642 855-226-9991
Cardio Diagnostics Holdings, Inc. (Filer) CIK: 0001870144 (see all company filings)

EIN.: 870925574 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41097 | Film No.: 221365583
SIC: 2835 In Vitro & In Vivo Diagnostic Substances